Discovery of a novel homozygous SOD1 truncating variant bolsters infantile SOD1 deficiency syndrome

dc.contributor.authorDoğan, Mustafa
dc.contributor.authorTeralı, Kerem
dc.contributor.authorEröz, Recep
dc.contributor.authorKılıç, Hüseyin
dc.contributor.authorGezdirici, Alper
dc.contributor.authorGönüllü, Burçin
dc.date.accessioned2024-07-01T06:29:08Z
dc.date.available2024-07-01T06:29:08Z
dc.date.issued2024
dc.departmentTıp Fakültesi
dc.description.abstractSuperoxide dismutase 1 (SOD1) is an important antioxidant enzyme whose main function is to neutralise superoxide free radicals in the cytoplasm. Heterozygous variants in SOD1 are responsible for a substantial percentage of familial amyotrophic lateral sclerosis (ALS) cases. Recently, several reports have shown that biallelic loss of SOD1 function results in a novel phenotype called infantile SOD1 deficiency syndrome, which is consistent with a recessive pattern of inheritance and can be distinguished from typical (adult-onset) ALS. Methods: We documented detailed family histories and clinical data, followed by whole-exome sequencing and family co-segregation analysis through Sanger sequencing. To facilitate comparisons, relevant data from fifteen previously reported patients with SOD1-related neurodevelopmental disorders were included. Results: This study presents a new Turkish family with two affected children exhibiting severe delayed motor development, infancy-onset loss of motor skills, axial hypotonia, tetraspasticity, and impaired cognitive functions. Genetic analysis revealed a novel homozygous frameshift variant in SOD1 (c.248dupG [p.Asp84Argfs*8]), with computational biochemical studies shedding light on the mechanistic aspects of SOD1 dysfunction. Conclusions: Our findings contribute an affirmative report of a fourth biallelic variant resulting in a severe clinical phenotype, reminiscent of those induced by previously identified homozygous loss-of-function SOD1 variants. This research not only advances our understanding of the pathogenesis of this debilitating neurological syndrome but also aligns with ongoing intensive efforts to comprehend and address SOD1-linked ALS.
dc.identifier.issn0301-4851
dc.identifier.issue1en_US
dc.identifier.scopusqualityQ2
dc.identifier.urihttps:/dx.doi.org/10.1007/s11033-024-09513-6
dc.identifier.urihttps://hdl.handle.net/20.500.12451/11999
dc.identifier.volume51en_US
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringer Science and Business Media B.V.
dc.relation.ispartofMolecular Biology Reports
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectAxial Hypotonia
dc.subjectLoss of Motor Skills
dc.subjectNon-amyotrophic Lateral Sclerosis
dc.subjectSOD1 Deficiency
dc.subjectTetraspasticity
dc.titleDiscovery of a novel homozygous SOD1 truncating variant bolsters infantile SOD1 deficiency syndrome
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
dogan-huseyin-2024.pdf
Boyut:
1.95 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: